SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-20-074946
Filing Date
2020-03-16
Accepted
2020-03-16 16:42:27
Documents
78
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d863964d10k.htm   iXBRL 10-K 2336760
2 EX-4.2 d863964dex42.htm EX-4.2 16232
3 EX-21.1 d863964dex211.htm EX-21.1 2181
4 EX-23.1 d863964dex231.htm EX-23.1 2858
5 EX-31.1 d863964dex311.htm EX-31.1 10246
6 EX-31.2 d863964dex312.htm EX-31.2 10242
7 EX-32.1 d863964dex321.htm EX-32.1 4999
13 GRAPHIC g863964g73a92.jpg GRAPHIC 27946
  Complete submission text file 0001193125-20-074946.txt   9395471

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cbay-20191231.xsd EX-101.SCH 49854
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20191231_cal.xml EX-101.CAL 53293
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20191231_def.xml EX-101.DEF 234759
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20191231_lab.xml EX-101.LAB 474201
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20191231_pre.xml EX-101.PRE 363759
19 EXTRACTED XBRL INSTANCE DOCUMENT d863964d10k_htm.xml XML 1956132
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36500 | Film No.: 20717761
SIC: 2834 Pharmaceutical Preparations